Nuvation Bio Inc
Change company Symbol lookup
Select an option...
NUVB Nuvation Bio Inc
HQGE Big M Entertainment Corp
JLL Jones Lang LaSalle Inc
CPOP Pop Culture Group Co Ltd
MCD McDonald's Corp
UBS UBS Group AG
ACTDU ArcLight Clean Transition Corp II
WESMF West Mining Corp
XIN Xinyuan Real Estate Co Ltd
MRCC Monroe Capital Corp
Go

Health Care : Pharmaceuticals |
Company profile

Nuvation Bio, Inc, formerly Panacea Acquisition Corp, is a biopharmaceutical company. The Company is engaged in developing differentiated and novel therapeutic candidates. Its portfolio includes distinct oncology therapeutic product candidates, each targeting some of the difficult-to-treat types of cancer. The Company’s drug discovery and development programs include a cyclin-dependent kinase (CDK) inhibitor program, a bromodomain and extra terminal protein (BET) inhibitor program, a WEE1 inhibitor program, an A2A adenosine receptor inhibitor program, and a drug-drug conjugate (DDC) platform that has compounds targeting hormone-driven cancers such as prostate, breast and ovarian cancers.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$9.63
Day's Change
0.58 (6.41%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.66
Day's Low
8.73
Volume
(Below Average)
Volume:
1,158,394

10-day average volume:
1,295,423
1,158,394
  • Prev Close
    9.05
  • Today's Open
    9.05
  • Day's Range
    8.73-9.66
  • Avg Vol (10-day)
    1.3M
  • Last (time)
    4:10p ET 12/06/21
  • Last (size)
    1.7K
  • 52-Wk Range
    7.30 - 15.23
    LowHigh
  • (05/26/21 - 11/24/21)
    31.92%
  • 64.1%
  • Market Cap
    2.1B
  • Shares Outstanding
    217.8M
  • -0.44
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 67.93
  • (% of float 11/15/21)
    5.52

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.